We evaluated the potential of IL-10 and TGF-β to inhibit the release of TNF-α and IL-1β from degenerative NP cells to determine if combining these two biologics might be a promising approach for the treatment of IDD. Here, TGFB1 is linked to intervertebral disk degenerative disorder.